Rising Pharmaceutical Expenditures and an Ageing Population Propel Growth of the European Generics Market.(Industry overview)

PR Newswire Europe, February, 2007

LONDON, February 13 /PRNewswire/ -- An ageing population and rising drug costs are underlining the increasingly critical role of cost-effective generic medicines. Simultaneously, the highly competitive generics industry is pressurising the mainstream pharmaceutical sector to develop innovative drugs.

"An ageing population, spiralling healthcare expenditures, and an immediate need for cheap, effective medicines will be the main drivers in the European generics market", notes Frost & Sullivan ( http://www.healthcare.frost.com) Research Analyst Sumanth Kambhammettu in a recent study on Pricing and Reimbursement Issues for Generics and Biosimilar Markets in Europe. "Various studies have indicated the cost savings obtained from generics and several governments...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here